2D miR_HR1_12
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Smad1
|
ENSMUSG00000031681.8 | SMAD family member 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Smad1 | mm10_v2_chr8_-_79399513_79399532 | -0.90 | 5.4e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_+_4082473 | 6.46 |
ENSMUST00000159148.1
|
Cabp2
|
calcium binding protein 2 |
chr6_-_55175019 | 6.07 |
ENSMUST00000003569.5
|
Inmt
|
indolethylamine N-methyltransferase |
chr7_+_24777172 | 5.64 |
ENSMUST00000038069.7
|
Ceacam10
|
carcinoembryonic antigen-related cell adhesion molecule 10 |
chr12_-_24680890 | 4.76 |
ENSMUST00000156453.2
|
Cys1
|
cystin 1 |
chr2_-_93452679 | 4.28 |
ENSMUST00000111257.1
ENSMUST00000145553.1 |
Cd82
|
CD82 antigen |
chr10_+_127866457 | 4.23 |
ENSMUST00000092058.3
|
BC089597
|
cDNA sequence BC089597 |
chr19_+_4081565 | 4.13 |
ENSMUST00000159593.1
|
Cabp2
|
calcium binding protein 2 |
chr8_-_111691002 | 4.10 |
ENSMUST00000034435.5
|
Ctrb1
|
chymotrypsinogen B1 |
chr13_-_3945349 | 3.90 |
ENSMUST00000058610.7
|
Ucn3
|
urocortin 3 |
chr1_+_93006328 | 3.65 |
ENSMUST00000059676.4
|
Aqp12
|
aquaporin 12 |
chr18_-_43737186 | 3.63 |
ENSMUST00000025381.2
|
Spink3
|
serine peptidase inhibitor, Kazal type 3 |
chr16_+_32756336 | 3.62 |
ENSMUST00000135753.1
|
Muc4
|
mucin 4 |
chr6_+_78380700 | 3.40 |
ENSMUST00000101272.1
|
Reg3a
|
regenerating islet-derived 3 alpha |
chr4_-_148500449 | 3.39 |
ENSMUST00000030840.3
|
Angptl7
|
angiopoietin-like 7 |
chr7_+_140835018 | 3.34 |
ENSMUST00000106050.1
ENSMUST00000026554.4 |
Urah
|
urate (5-hydroxyiso-) hydrolase |
chr10_-_75797728 | 3.33 |
ENSMUST00000139724.1
|
Gstt1
|
glutathione S-transferase, theta 1 |
chr2_-_28563362 | 3.18 |
ENSMUST00000028161.5
|
Cel
|
carboxyl ester lipase |
chr4_-_149454971 | 3.13 |
ENSMUST00000030848.2
|
Rbp7
|
retinol binding protein 7, cellular |
chr7_-_45333754 | 3.05 |
ENSMUST00000042194.8
|
Trpm4
|
transient receptor potential cation channel, subfamily M, member 4 |
chr2_+_70562854 | 3.03 |
ENSMUST00000130998.1
|
Gad1
|
glutamate decarboxylase 1 |
chr11_+_49794157 | 2.96 |
ENSMUST00000020629.4
|
Gfpt2
|
glutamine fructose-6-phosphate transaminase 2 |
chr19_+_58728887 | 2.94 |
ENSMUST00000048644.5
|
Pnliprp1
|
pancreatic lipase related protein 1 |
chr9_+_87144285 | 2.81 |
ENSMUST00000113149.1
ENSMUST00000143779.1 ENSMUST00000179313.1 ENSMUST00000049457.7 ENSMUST00000153444.1 |
Mrap2
|
melanocortin 2 receptor accessory protein 2 |
chr2_+_70563435 | 2.81 |
ENSMUST00000123330.1
|
Gad1
|
glutamate decarboxylase 1 |
chr14_-_51146757 | 2.80 |
ENSMUST00000080126.2
|
Rnase1
|
ribonuclease, RNase A family, 1 (pancreatic) |
chr11_+_69964758 | 2.78 |
ENSMUST00000108597.1
ENSMUST00000060651.5 ENSMUST00000108596.1 |
Cldn7
|
claudin 7 |
chr4_-_43046196 | 2.77 |
ENSMUST00000036462.5
|
Fam214b
|
family with sequence similarity 214, member B |
chr16_-_17838173 | 2.75 |
ENSMUST00000118960.1
|
Car15
|
carbonic anhydrase 15 |
chr11_-_109722214 | 2.68 |
ENSMUST00000020938.7
|
Fam20a
|
family with sequence similarity 20, member A |
chr3_-_107943705 | 2.68 |
ENSMUST00000106680.1
ENSMUST00000106684.1 ENSMUST00000106685.2 |
Gstm6
|
glutathione S-transferase, mu 6 |
chr11_+_69965396 | 2.67 |
ENSMUST00000018713.6
|
Cldn7
|
claudin 7 |
chr5_+_43818893 | 2.66 |
ENSMUST00000101237.4
|
Bst1
|
bone marrow stromal cell antigen 1 |
chr13_-_114932035 | 2.64 |
ENSMUST00000056117.8
|
Itga2
|
integrin alpha 2 |
chrX_+_101377267 | 2.60 |
ENSMUST00000052130.7
|
Gjb1
|
gap junction protein, beta 1 |
chr6_-_65144908 | 2.54 |
ENSMUST00000031982.4
|
Hpgds
|
hematopoietic prostaglandin D synthase |
chr1_-_10009098 | 2.51 |
ENSMUST00000176398.1
ENSMUST00000027049.3 |
Ppp1r42
|
protein phosphatase 1, regulatory subunit 42 |
chr10_-_81291227 | 2.46 |
ENSMUST00000045744.6
|
Tjp3
|
tight junction protein 3 |
chr5_+_21372642 | 2.46 |
ENSMUST00000035799.5
|
Fgl2
|
fibrinogen-like protein 2 |
chr6_+_55336424 | 2.46 |
ENSMUST00000004774.3
|
Aqp1
|
aquaporin 1 |
chr6_+_49367739 | 2.42 |
ENSMUST00000060561.8
ENSMUST00000121903.1 ENSMUST00000134786.1 |
Fam221a
|
family with sequence similarity 221, member A |
chr8_+_124576105 | 2.41 |
ENSMUST00000093033.5
ENSMUST00000133086.1 |
Capn9
|
calpain 9 |
chr11_+_61065798 | 2.41 |
ENSMUST00000041944.2
ENSMUST00000108717.2 |
Kcnj12
|
potassium inwardly-rectifying channel, subfamily J, member 12 |
chr7_-_4164442 | 2.39 |
ENSMUST00000140410.1
ENSMUST00000143825.1 |
Cdc42ep5
|
CDC42 effector protein (Rho GTPase binding) 5 |
chr6_+_78370877 | 2.39 |
ENSMUST00000096904.3
|
Reg3b
|
regenerating islet-derived 3 beta |
chr7_-_101864093 | 2.38 |
ENSMUST00000106981.1
|
Folr1
|
folate receptor 1 (adult) |
chr17_+_85090647 | 2.37 |
ENSMUST00000095188.5
|
Camkmt
|
calmodulin-lysine N-methyltransferase |
chr7_-_30856178 | 2.36 |
ENSMUST00000094583.1
|
Ffar3
|
free fatty acid receptor 3 |
chr7_-_140082489 | 2.35 |
ENSMUST00000026541.7
|
Caly
|
calcyon neuron-specific vesicular protein |
chr11_+_69966896 | 2.33 |
ENSMUST00000151515.1
|
Cldn7
|
claudin 7 |
chr6_+_90619241 | 2.33 |
ENSMUST00000032177.8
|
Slc41a3
|
solute carrier family 41, member 3 |
chr11_+_120530688 | 2.32 |
ENSMUST00000026119.7
|
Gcgr
|
glucagon receptor |
chr7_-_100662414 | 2.28 |
ENSMUST00000079176.6
|
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr15_+_31224371 | 2.27 |
ENSMUST00000044524.9
|
Dap
|
death-associated protein |
chr19_-_10457447 | 2.27 |
ENSMUST00000171400.2
|
Lrrc10b
|
leucine rich repeat containing 10B |
chr19_-_3414464 | 2.26 |
ENSMUST00000025842.6
|
Gal
|
galanin |
chr10_+_79664553 | 2.23 |
ENSMUST00000020554.6
|
Madcam1
|
mucosal vascular addressin cell adhesion molecule 1 |
chr11_-_3931789 | 2.23 |
ENSMUST00000109992.1
ENSMUST00000109988.1 |
Tcn2
|
transcobalamin 2 |
chr9_-_45204083 | 2.22 |
ENSMUST00000034599.8
|
Tmprss4
|
transmembrane protease, serine 4 |
chr11_-_3931960 | 2.19 |
ENSMUST00000109990.1
ENSMUST00000020710.4 ENSMUST00000109989.3 ENSMUST00000109991.1 ENSMUST00000109993.2 |
Tcn2
|
transcobalamin 2 |
chr4_+_63215402 | 2.19 |
ENSMUST00000036300.6
|
Col27a1
|
collagen, type XXVII, alpha 1 |
chr7_-_45370559 | 2.19 |
ENSMUST00000003971.7
|
Lin7b
|
lin-7 homolog B (C. elegans) |
chr7_+_19411086 | 2.18 |
ENSMUST00000003643.1
|
Ckm
|
creatine kinase, muscle |
chr19_+_4839366 | 2.15 |
ENSMUST00000088653.2
|
Ccdc87
|
coiled-coil domain containing 87 |
chr6_+_41521782 | 2.13 |
ENSMUST00000070380.4
|
Prss2
|
protease, serine, 2 |
chr5_+_125003440 | 2.12 |
ENSMUST00000036109.3
|
Fam101a
|
family with sequence similarity 101, member A |
chr2_-_30903255 | 2.12 |
ENSMUST00000102852.3
|
Ptges
|
prostaglandin E synthase |
chr4_-_63154130 | 2.10 |
ENSMUST00000030041.4
|
Ambp
|
alpha 1 microglobulin/bikunin |
chr4_-_131672133 | 2.09 |
ENSMUST00000144212.1
|
Gm12962
|
predicted gene 12962 |
chr3_-_107986360 | 2.06 |
ENSMUST00000066530.6
|
Gstm2
|
glutathione S-transferase, mu 2 |
chr17_-_26199008 | 2.05 |
ENSMUST00000142410.1
ENSMUST00000120333.1 ENSMUST00000039113.7 |
Pdia2
|
protein disulfide isomerase associated 2 |
chr14_-_30943275 | 2.05 |
ENSMUST00000006704.8
ENSMUST00000163118.1 |
Itih1
|
inter-alpha trypsin inhibitor, heavy chain 1 |
chr11_+_115154139 | 2.05 |
ENSMUST00000021076.5
|
Rab37
|
RAB37, member of RAS oncogene family |
chr7_+_141079125 | 2.02 |
ENSMUST00000159375.1
|
Pkp3
|
plakophilin 3 |
chrX_-_74645635 | 2.02 |
ENSMUST00000114119.1
|
Gm5640
|
predicted gene 5640 |
chr7_-_31055594 | 2.01 |
ENSMUST00000039909.6
|
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr6_-_113719880 | 2.00 |
ENSMUST00000064993.5
|
Ghrl
|
ghrelin |
chr4_-_141825997 | 2.00 |
ENSMUST00000102481.3
|
Cela2a
|
chymotrypsin-like elastase family, member 2A |
chr9_+_107295928 | 2.00 |
ENSMUST00000085102.5
|
Cish
|
cytokine inducible SH2-containing protein |
chr1_+_120340569 | 1.99 |
ENSMUST00000037286.8
|
C1ql2
|
complement component 1, q subcomponent-like 2 |
chr14_+_65971049 | 1.98 |
ENSMUST00000128539.1
|
Clu
|
clusterin |
chr8_+_105413614 | 1.97 |
ENSMUST00000109355.2
|
Lrrc36
|
leucine rich repeat containing 36 |
chr4_+_120854786 | 1.95 |
ENSMUST00000071093.2
|
Rims3
|
regulating synaptic membrane exocytosis 3 |
chr7_-_45759527 | 1.94 |
ENSMUST00000075571.7
|
Sult2b1
|
sulfotransferase family, cytosolic, 2B, member 1 |
chr7_-_101870683 | 1.94 |
ENSMUST00000106986.2
ENSMUST00000106985.1 |
Folr1
|
folate receptor 1 (adult) |
chr3_+_146117451 | 1.93 |
ENSMUST00000140214.1
|
Mcoln3
|
mucolipin 3 |
chr14_-_30626196 | 1.93 |
ENSMUST00000112210.3
ENSMUST00000112211.2 ENSMUST00000112208.1 |
Prkcd
|
protein kinase C, delta |
chr11_-_120648104 | 1.90 |
ENSMUST00000026134.2
|
Myadml2
|
myeloid-associated differentiation marker-like 2 |
chr19_-_6996025 | 1.89 |
ENSMUST00000041686.3
ENSMUST00000180765.1 |
Nudt22
|
nudix (nucleoside diphosphate linked moiety X)-type motif 22 |
chr12_+_112678803 | 1.89 |
ENSMUST00000174780.1
ENSMUST00000169593.1 ENSMUST00000173942.1 |
Zbtb42
|
zinc finger and BTB domain containing 42 |
chr1_-_121328024 | 1.88 |
ENSMUST00000003818.7
|
Insig2
|
insulin induced gene 2 |
chr2_-_127208274 | 1.87 |
ENSMUST00000056146.1
|
1810024B03Rik
|
RIKEN cDNA 1810024B03 gene |
chr4_+_120161206 | 1.87 |
ENSMUST00000030384.4
|
Edn2
|
endothelin 2 |
chr2_+_164562579 | 1.86 |
ENSMUST00000017867.3
ENSMUST00000109344.2 ENSMUST00000109345.2 |
Wfdc2
|
WAP four-disulfide core domain 2 |
chr13_-_71963713 | 1.85 |
ENSMUST00000077337.8
|
Irx1
|
Iroquois related homeobox 1 (Drosophila) |
chr7_-_127993831 | 1.83 |
ENSMUST00000033056.3
|
Pycard
|
PYD and CARD domain containing |
chr13_-_48625571 | 1.83 |
ENSMUST00000035824.9
|
Ptpdc1
|
protein tyrosine phosphatase domain containing 1 |
chr11_+_115887601 | 1.83 |
ENSMUST00000167507.2
|
Myo15b
|
myosin XVB |
chr2_-_164356067 | 1.82 |
ENSMUST00000165980.1
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr13_-_34345174 | 1.82 |
ENSMUST00000040336.5
|
Slc22a23
|
solute carrier family 22, member 23 |
chr19_+_56461629 | 1.82 |
ENSMUST00000178590.1
ENSMUST00000039666.6 |
Plekhs1
|
pleckstrin homology domain containing, family S member 1 |
chr11_-_102107822 | 1.81 |
ENSMUST00000177304.1
ENSMUST00000017455.8 |
Pyy
|
peptide YY |
chr3_+_89436699 | 1.81 |
ENSMUST00000038942.3
ENSMUST00000130858.1 |
Pbxip1
|
pre B cell leukemia transcription factor interacting protein 1 |
chr15_-_32244632 | 1.79 |
ENSMUST00000181536.1
|
0610007N19Rik
|
RIKEN cDNA 0610007N19 |
chr9_+_66158206 | 1.79 |
ENSMUST00000034944.2
|
Dapk2
|
death-associated protein kinase 2 |
chr17_-_31144271 | 1.79 |
ENSMUST00000024826.7
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr1_+_88138364 | 1.79 |
ENSMUST00000014263.4
|
Ugt1a6a
|
UDP glucuronosyltransferase 1 family, polypeptide A6A |
chr4_+_104766334 | 1.79 |
ENSMUST00000065072.6
|
C8b
|
complement component 8, beta polypeptide |
chr7_-_66427469 | 1.78 |
ENSMUST00000015278.7
|
Aldh1a3
|
aldehyde dehydrogenase family 1, subfamily A3 |
chr15_-_100687908 | 1.77 |
ENSMUST00000023775.7
|
Cela1
|
chymotrypsin-like elastase family, member 1 |
chr4_+_108879130 | 1.76 |
ENSMUST00000106651.2
|
Rab3b
|
RAB3B, member RAS oncogene family |
chr3_-_107986408 | 1.75 |
ENSMUST00000012348.2
|
Gstm2
|
glutathione S-transferase, mu 2 |
chr1_-_158958367 | 1.74 |
ENSMUST00000159861.2
|
Pappa2
|
pappalysin 2 |
chr7_-_27333602 | 1.73 |
ENSMUST00000118583.1
ENSMUST00000118961.1 ENSMUST00000121175.1 |
Ltbp4
|
latent transforming growth factor beta binding protein 4 |
chr3_+_87796938 | 1.73 |
ENSMUST00000029711.2
ENSMUST00000107582.2 |
Insrr
|
insulin receptor-related receptor |
chr15_+_84720052 | 1.72 |
ENSMUST00000006029.4
ENSMUST00000172307.2 |
Arhgap8
|
Rho GTPase activating protein 8 |
chr10_-_61147625 | 1.70 |
ENSMUST00000122259.1
|
Sgpl1
|
sphingosine phosphate lyase 1 |
chrX_+_134295225 | 1.70 |
ENSMUST00000037687.7
|
Tmem35
|
transmembrane protein 35 |
chr3_+_135825648 | 1.69 |
ENSMUST00000180196.1
|
Slc39a8
|
solute carrier family 39 (metal ion transporter), member 8 |
chr18_-_3337467 | 1.67 |
ENSMUST00000154135.1
|
Crem
|
cAMP responsive element modulator |
chr7_-_25539845 | 1.67 |
ENSMUST00000066503.7
ENSMUST00000064862.6 |
Ceacam2
|
carcinoembryonic antigen-related cell adhesion molecule 2 |
chr6_-_71144338 | 1.67 |
ENSMUST00000074241.7
ENSMUST00000160918.1 |
Thnsl2
|
threonine synthase-like 2 (bacterial) |
chr3_-_54915867 | 1.67 |
ENSMUST00000070342.3
|
Sertm1
|
serine rich and transmembrane domain containing 1 |
chr3_-_151837451 | 1.67 |
ENSMUST00000029670.5
|
Ptgfr
|
prostaglandin F receptor |
chr4_+_106733883 | 1.66 |
ENSMUST00000047620.2
|
Fam151a
|
family with sequence simliarity 151, member A |
chr18_-_3337614 | 1.66 |
ENSMUST00000150235.1
ENSMUST00000154470.1 |
Crem
|
cAMP responsive element modulator |
chr7_-_131322292 | 1.66 |
ENSMUST00000046611.7
|
Cuzd1
|
CUB and zona pellucida-like domains 1 |
chr17_-_85090204 | 1.66 |
ENSMUST00000072406.3
ENSMUST00000171795.1 |
Prepl
|
prolyl endopeptidase-like |
chr1_+_16688405 | 1.65 |
ENSMUST00000026881.4
|
Ly96
|
lymphocyte antigen 96 |
chr14_+_32991379 | 1.64 |
ENSMUST00000038956.4
|
Lrrc18
|
leucine rich repeat containing 18 |
chr4_-_111902754 | 1.64 |
ENSMUST00000102719.1
ENSMUST00000102721.1 |
Slc5a9
|
solute carrier family 5 (sodium/glucose cotransporter), member 9 |
chr1_+_131599239 | 1.64 |
ENSMUST00000027690.6
|
Avpr1b
|
arginine vasopressin receptor 1B |
chr3_-_113574242 | 1.63 |
ENSMUST00000142505.2
|
Amy1
|
amylase 1, salivary |
chr1_-_121327672 | 1.63 |
ENSMUST00000159085.1
ENSMUST00000159125.1 ENSMUST00000161818.1 |
Insig2
|
insulin induced gene 2 |
chr4_+_108879063 | 1.63 |
ENSMUST00000106650.2
|
Rab3b
|
RAB3B, member RAS oncogene family |
chr11_+_83709015 | 1.62 |
ENSMUST00000001009.7
|
Wfdc18
|
WAP four-disulfide core domain 18 |
chr15_+_31568791 | 1.61 |
ENSMUST00000162532.1
|
Cmbl
|
carboxymethylenebutenolidase-like (Pseudomonas) |
chr3_+_94693556 | 1.61 |
ENSMUST00000090848.3
ENSMUST00000173981.1 ENSMUST00000173849.1 ENSMUST00000174223.1 |
Selenbp2
|
selenium binding protein 2 |
chr7_+_4119556 | 1.61 |
ENSMUST00000079415.5
|
Ttyh1
|
tweety homolog 1 (Drosophila) |
chr6_-_112489808 | 1.60 |
ENSMUST00000053306.6
|
Oxtr
|
oxytocin receptor |
chr8_-_105938384 | 1.60 |
ENSMUST00000034369.8
|
Psmb10
|
proteasome (prosome, macropain) subunit, beta type 10 |
chr8_+_71689214 | 1.60 |
ENSMUST00000034261.7
|
Insl3
|
insulin-like 3 |
chr9_+_46998931 | 1.59 |
ENSMUST00000178065.1
|
Gm4791
|
predicted gene 4791 |
chr17_+_47436731 | 1.59 |
ENSMUST00000150819.2
|
AI661453
|
expressed sequence AI661453 |
chr19_+_16956110 | 1.59 |
ENSMUST00000087689.4
|
Prune2
|
prune homolog 2 (Drosophila) |
chr6_-_41314700 | 1.59 |
ENSMUST00000064324.5
|
Try5
|
trypsin 5 |
chr7_-_101870778 | 1.59 |
ENSMUST00000001882.4
ENSMUST00000126204.1 ENSMUST00000155311.1 ENSMUST00000106983.1 ENSMUST00000123630.1 |
Folr1
|
folate receptor 1 (adult) |
chr15_-_75747922 | 1.57 |
ENSMUST00000062002.4
|
Mafa
|
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A (avian) |
chr19_+_34640871 | 1.57 |
ENSMUST00000102824.3
|
Ifit1
|
interferon-induced protein with tetratricopeptide repeats 1 |
chr7_-_25539950 | 1.57 |
ENSMUST00000044547.8
|
Ceacam2
|
carcinoembryonic antigen-related cell adhesion molecule 2 |
chr8_+_109990430 | 1.55 |
ENSMUST00000001720.7
ENSMUST00000143741.1 |
Tat
|
tyrosine aminotransferase |
chr2_+_144556229 | 1.54 |
ENSMUST00000143573.1
ENSMUST00000028916.8 ENSMUST00000155258.1 |
Sec23b
|
SEC23B (S. cerevisiae) |
chr10_+_5639210 | 1.54 |
ENSMUST00000019906.4
|
Vip
|
vasoactive intestinal polypeptide |
chr3_+_135825788 | 1.54 |
ENSMUST00000167390.1
|
Slc39a8
|
solute carrier family 39 (metal ion transporter), member 8 |
chr17_+_55970451 | 1.53 |
ENSMUST00000044216.6
|
Shd
|
src homology 2 domain-containing transforming protein D |
chrX_-_163761323 | 1.52 |
ENSMUST00000059320.2
|
Rnf138rt1
|
ring finger protein 138, retrogene 1 |
chr17_+_24488773 | 1.52 |
ENSMUST00000024958.7
|
Caskin1
|
CASK interacting protein 1 |
chr4_+_137862237 | 1.52 |
ENSMUST00000102518.3
|
Ece1
|
endothelin converting enzyme 1 |
chr11_+_61485431 | 1.52 |
ENSMUST00000064783.3
ENSMUST00000040522.6 |
Mfap4
|
microfibrillar-associated protein 4 |
chr11_+_87760533 | 1.52 |
ENSMUST00000039627.5
ENSMUST00000100644.3 |
Bzrap1
|
benzodiazepine receptor associated protein 1 |
chr3_+_102469918 | 1.52 |
ENSMUST00000106925.2
ENSMUST00000035952.3 |
Ngf
|
nerve growth factor |
chr14_+_29968308 | 1.51 |
ENSMUST00000112268.1
|
Selk
|
selenoprotein K |
chr5_+_135168283 | 1.51 |
ENSMUST00000031692.5
|
Bcl7b
|
B cell CLL/lymphoma 7B |
chr2_+_122765377 | 1.50 |
ENSMUST00000124460.1
ENSMUST00000147475.1 |
Sqrdl
|
sulfide quinone reductase-like (yeast) |
chr13_+_48968287 | 1.50 |
ENSMUST00000180775.1
|
Fam120aos
|
family with sequence similarity 120A opposite strand |
chr8_+_62951195 | 1.49 |
ENSMUST00000118003.1
|
Spock3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 3 |
chr11_-_83592981 | 1.49 |
ENSMUST00000019071.3
|
Ccl6
|
chemokine (C-C motif) ligand 6 |
chr11_-_99986593 | 1.49 |
ENSMUST00000105050.2
|
Krtap16-1
|
keratin associated protein 16-1 |
chr6_-_48445825 | 1.48 |
ENSMUST00000114561.2
|
Zfp467
|
zinc finger protein 467 |
chr7_-_126625676 | 1.46 |
ENSMUST00000032961.3
|
Nupr1
|
nuclear protein transcription regulator 1 |
chr2_+_129592914 | 1.46 |
ENSMUST00000103203.1
|
Sirpa
|
signal-regulatory protein alpha |
chr2_-_164356507 | 1.46 |
ENSMUST00000109367.3
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr9_-_101034857 | 1.45 |
ENSMUST00000142676.1
ENSMUST00000149322.1 |
Pccb
|
propionyl Coenzyme A carboxylase, beta polypeptide |
chr13_-_52530827 | 1.45 |
ENSMUST00000057442.6
|
Diras2
|
DIRAS family, GTP-binding RAS-like 2 |
chr7_-_100656953 | 1.44 |
ENSMUST00000107046.1
ENSMUST00000107045.1 ENSMUST00000139708.1 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr4_-_138367966 | 1.44 |
ENSMUST00000030535.3
|
Cda
|
cytidine deaminase |
chr10_+_75037066 | 1.44 |
ENSMUST00000147802.1
ENSMUST00000020391.5 |
Rab36
|
RAB36, member RAS oncogene family |
chr15_+_101293196 | 1.44 |
ENSMUST00000071328.6
|
6030408B16Rik
|
RIKEN cDNA 6030408B16 gene |
chr2_+_163122605 | 1.44 |
ENSMUST00000144092.1
|
Gm11454
|
predicted gene 11454 |
chr18_+_20665250 | 1.43 |
ENSMUST00000075312.3
|
Ttr
|
transthyretin |
chr3_-_129969989 | 1.43 |
ENSMUST00000146340.1
|
Ccdc109b
|
coiled-coil domain containing 109B |
chr16_+_31878810 | 1.43 |
ENSMUST00000023464.5
|
Mfi2
|
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 |
chr13_-_34919992 | 1.43 |
ENSMUST00000021851.6
|
Fam217a
|
family with sequence similarity 217, member A |
chr11_-_116828000 | 1.42 |
ENSMUST00000047715.5
ENSMUST00000021170.2 |
Mxra7
|
matrix-remodelling associated 7 |
chr11_-_29247208 | 1.42 |
ENSMUST00000020754.3
|
Ccdc104
|
coiled-coil domain containing 104 |
chr9_+_59578192 | 1.41 |
ENSMUST00000118549.1
ENSMUST00000034840.3 |
Celf6
|
CUGBP, Elav-like family member 6 |
chr19_-_57118981 | 1.41 |
ENSMUST00000111528.1
ENSMUST00000111529.1 ENSMUST00000104902.2 |
Ablim1
|
actin-binding LIM protein 1 |
chr13_+_72628802 | 1.41 |
ENSMUST00000074372.4
|
Irx2
|
Iroquois related homeobox 2 (Drosophila) |
chr4_+_41762309 | 1.40 |
ENSMUST00000108042.2
|
Il11ra1
|
interleukin 11 receptor, alpha chain 1 |
chr7_+_44198191 | 1.40 |
ENSMUST00000085450.2
|
Klk1b3
|
kallikrein 1-related peptidase b3 |
chrX_+_73483602 | 1.39 |
ENSMUST00000033741.8
ENSMUST00000169489.1 |
Bgn
|
biglycan |
chr15_+_102102926 | 1.39 |
ENSMUST00000169627.1
ENSMUST00000046144.9 |
Tenc1
|
tensin like C1 domain-containing phosphatase |
chr9_-_101034892 | 1.39 |
ENSMUST00000035116.5
|
Pccb
|
propionyl Coenzyme A carboxylase, beta polypeptide |
chr18_+_37489465 | 1.39 |
ENSMUST00000055949.2
|
Pcdhb18
|
protocadherin beta 18 |
chr13_-_92131494 | 1.38 |
ENSMUST00000099326.3
ENSMUST00000146492.1 |
Rasgrf2
|
RAS protein-specific guanine nucleotide-releasing factor 2 |
chr9_+_119063429 | 1.38 |
ENSMUST00000141185.1
ENSMUST00000126251.1 ENSMUST00000136561.1 |
Vill
|
villin-like |
chr19_+_5406815 | 1.38 |
ENSMUST00000174412.1
ENSMUST00000153017.2 |
4930481A15Rik
|
RIKEN cDNA 4930481A15 gene |
chr8_+_119666498 | 1.37 |
ENSMUST00000024107.5
|
Wfdc1
|
WAP four-disulfide core domain 1 |
chr7_-_31054815 | 1.37 |
ENSMUST00000071697.4
ENSMUST00000108110.3 |
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr12_+_36157124 | 1.36 |
ENSMUST00000041640.3
|
Ankmy2
|
ankyrin repeat and MYND domain containing 2 |
chr11_+_121237216 | 1.36 |
ENSMUST00000103015.3
|
Narf
|
nuclear prelamin A recognition factor |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.3 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
1.2 | 3.6 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
1.1 | 3.3 | GO:0042196 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
1.1 | 4.2 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
1.0 | 3.8 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.9 | 3.6 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.9 | 3.6 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.9 | 2.7 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.9 | 5.3 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.9 | 5.3 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.8 | 5.8 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.8 | 2.5 | GO:0035377 | transepithelial water transport(GO:0035377) |
0.8 | 2.4 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.8 | 2.4 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.8 | 2.3 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.8 | 2.3 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.7 | 3.7 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.7 | 3.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.7 | 6.3 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.6 | 3.1 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.6 | 3.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.6 | 1.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.6 | 1.8 | GO:0060166 | olfactory pit development(GO:0060166) |
0.6 | 7.6 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.6 | 1.1 | GO:1904000 | positive regulation of eating behavior(GO:1904000) positive regulation of small intestine smooth muscle contraction(GO:1904349) |
0.6 | 2.2 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.5 | 1.6 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.5 | 3.8 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.5 | 2.2 | GO:0015938 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) acetyl-CoA catabolic process(GO:0046356) |
0.5 | 5.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.5 | 0.5 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.5 | 1.0 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.5 | 1.5 | GO:0048389 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
0.5 | 2.0 | GO:0015801 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.5 | 1.5 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.5 | 1.5 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) negative regulation of connective tissue replacement(GO:1905204) |
0.5 | 1.5 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.5 | 2.0 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.5 | 1.0 | GO:0046271 | coumarin metabolic process(GO:0009804) phenylpropanoid catabolic process(GO:0046271) |
0.5 | 1.9 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.5 | 1.0 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.5 | 5.7 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.5 | 2.9 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.5 | 9.1 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.5 | 5.6 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.5 | 2.3 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.5 | 0.5 | GO:0007037 | vacuolar phosphate transport(GO:0007037) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.5 | 1.4 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.5 | 1.4 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.4 | 1.8 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.4 | 2.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.4 | 1.7 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.4 | 1.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.4 | 1.3 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.4 | 1.3 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.4 | 5.5 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.4 | 1.7 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.4 | 1.2 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.4 | 1.2 | GO:2000451 | positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) |
0.4 | 1.6 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
0.4 | 0.4 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.4 | 2.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.4 | 0.8 | GO:0034757 | negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
0.4 | 2.0 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.4 | 1.9 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.4 | 1.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.4 | 4.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 1.9 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.4 | 0.8 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.4 | 0.4 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.4 | 0.4 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.4 | 1.5 | GO:0070459 | prolactin secretion(GO:0070459) |
0.4 | 1.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.4 | 0.7 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.4 | 1.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.4 | 0.4 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.4 | 0.4 | GO:0050787 | detoxification of mercury ion(GO:0050787) |
0.4 | 3.6 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.4 | 1.1 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.4 | 1.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 2.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.4 | 1.8 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.3 | 3.8 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 0.3 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.3 | 2.4 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.3 | 2.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 1.4 | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.3 | 1.4 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.3 | 2.0 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 0.7 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.3 | 1.0 | GO:0035799 | ureter maturation(GO:0035799) |
0.3 | 2.0 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.3 | 3.7 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.3 | 2.6 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.3 | 0.3 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.3 | 1.3 | GO:1904451 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.3 | 1.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 1.6 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.3 | 4.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 1.6 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.3 | 3.3 | GO:0070166 | enamel mineralization(GO:0070166) |
0.3 | 0.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 0.9 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.3 | 2.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 1.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 1.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.3 | 1.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 1.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 1.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.3 | 0.9 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.3 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.3 | 1.1 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.3 | 0.8 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
0.3 | 0.8 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.3 | 0.8 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.3 | 1.4 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 1.7 | GO:0098963 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.3 | 2.2 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 3.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.3 | 2.2 | GO:0035768 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.3 | 0.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.3 | 2.7 | GO:0009650 | UV protection(GO:0009650) |
0.3 | 1.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.3 | 1.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.3 | 0.3 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 0.8 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.3 | 1.0 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.3 | 1.8 | GO:2001199 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 1.0 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.3 | 0.8 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.3 | 0.8 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.3 | 1.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 1.0 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.3 | 0.5 | GO:0061517 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) |
0.3 | 2.3 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.3 | 0.3 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.3 | 1.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.3 | 1.8 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.3 | 3.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 1.0 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.2 | 0.7 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.2 | 0.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.7 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.2 | 0.7 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.2 | 1.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.5 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.2 | 0.2 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.2 | 1.0 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.2 | 0.7 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.2 | 0.7 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 0.7 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 0.5 | GO:0070268 | cornification(GO:0070268) |
0.2 | 0.9 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.7 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 0.9 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.2 | 0.7 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.2 | 0.7 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.2 | 3.1 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.2 | 1.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 1.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 1.3 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.4 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.2 | 1.1 | GO:0050904 | diapedesis(GO:0050904) |
0.2 | 0.9 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.2 | 0.4 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.2 | 1.9 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 0.6 | GO:0071846 | actin filament debranching(GO:0071846) |
0.2 | 1.1 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.2 | 0.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.2 | 0.6 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.2 | 1.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.2 | 0.8 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.2 | 0.2 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
0.2 | 2.1 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.2 | 1.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 1.4 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 0.8 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.2 | 0.6 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.2 | 0.2 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.2 | 0.8 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.2 | 0.6 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 1.0 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.2 | 1.4 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.2 | 2.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 2.0 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.2 | 0.6 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.2 | 1.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.2 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.2 | 1.8 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.2 | 0.8 | GO:0032218 | riboflavin transport(GO:0032218) |
0.2 | 0.4 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.2 | 1.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 0.6 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.2 | 0.8 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.2 | 0.8 | GO:0022009 | central nervous system vasculogenesis(GO:0022009) |
0.2 | 0.6 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.2 | 0.8 | GO:0060031 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.2 | 0.9 | GO:0042117 | monocyte activation(GO:0042117) |
0.2 | 1.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 0.2 | GO:0060168 | regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.2 | 1.1 | GO:2000064 | regulation of cortisol biosynthetic process(GO:2000064) |
0.2 | 1.7 | GO:0071569 | protein ufmylation(GO:0071569) |
0.2 | 0.9 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.2 | 0.6 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
0.2 | 0.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 0.6 | GO:0060290 | transdifferentiation(GO:0060290) |
0.2 | 0.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 1.8 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 0.4 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.2 | 0.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 1.4 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.2 | 0.2 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.2 | 1.1 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.2 | 2.3 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 1.8 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.2 | 0.5 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.2 | 1.4 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.2 | 1.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.2 | 0.7 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 2.1 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.2 | 2.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.2 | 1.4 | GO:0032264 | IMP salvage(GO:0032264) |
0.2 | 1.6 | GO:0070472 | regulation of uterine smooth muscle contraction(GO:0070472) |
0.2 | 0.5 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 1.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 2.0 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.2 | 1.4 | GO:0021891 | olfactory bulb interneuron differentiation(GO:0021889) olfactory bulb interneuron development(GO:0021891) |
0.2 | 0.8 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.2 | 2.0 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.2 | 0.2 | GO:1904732 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
0.2 | 0.2 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.2 | 0.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 1.0 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.2 | 1.2 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.2 | 0.3 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.2 | 0.2 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.2 | 0.5 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.2 | 0.5 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 0.5 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.2 | 4.1 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.2 | 0.7 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 1.0 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 2.0 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 0.3 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.2 | 0.7 | GO:0033366 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
0.2 | 0.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.2 | 0.3 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.2 | 0.6 | GO:0021586 | pons maturation(GO:0021586) |
0.2 | 1.6 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 0.6 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) |
0.2 | 0.5 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 0.8 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 0.6 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.2 | 0.2 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) |
0.2 | 0.6 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.2 | 2.8 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 0.6 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 0.5 | GO:0035106 | operant conditioning(GO:0035106) |
0.2 | 0.6 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.2 | 1.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 0.9 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.2 | 0.6 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.2 | 0.5 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.2 | 1.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 0.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.9 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.2 | 0.6 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.2 | 0.6 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 1.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.2 | 0.5 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 1.0 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 1.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 0.3 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.1 | 0.1 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.1 | 1.9 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 3.2 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.7 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 4.0 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.4 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 1.7 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.7 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.3 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 2.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 1.0 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.3 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.1 | 0.7 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.1 | 2.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.3 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.1 | 0.8 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.1 | 0.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 4.6 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.4 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
0.1 | 0.7 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.1 | 0.8 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 2.3 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.9 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.1 | 0.3 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 2.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 1.5 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.1 | 1.6 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.8 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.3 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.3 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.1 | 0.9 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.5 | GO:2001274 | positive regulation of fat cell proliferation(GO:0070346) negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 0.4 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.1 | 0.5 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.1 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.1 | 0.8 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.3 | GO:0046882 | negative regulation of gonadotropin secretion(GO:0032277) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.4 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.3 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 0.5 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.1 | 0.6 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 1.2 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 1.5 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.9 | GO:0044062 | regulation of excretion(GO:0044062) |
0.1 | 0.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 1.1 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.9 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.4 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.1 | 5.3 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.5 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) fatty-acyl-CoA catabolic process(GO:0036115) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.1 | 0.2 | GO:0060003 | copper ion export(GO:0060003) |
0.1 | 0.6 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.6 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.2 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 0.6 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.1 | 1.9 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.6 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.1 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 1.4 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.7 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.1 | 0.1 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.1 | 4.5 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.1 | 0.7 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.2 | GO:0048880 | sensory system development(GO:0048880) |
0.1 | 2.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.5 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 0.3 | GO:0032095 | regulation of response to food(GO:0032095) |
0.1 | 0.6 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.6 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.1 | 0.6 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 0.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.1 | 0.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 3.4 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.1 | 1.9 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.8 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 1.1 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.1 | 0.9 | GO:1901629 | regulation of presynaptic membrane organization(GO:1901629) |
0.1 | 0.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.4 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.1 | 2.0 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.2 | GO:0099645 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) protein localization to postsynaptic specialization membrane(GO:0099633) neurotransmitter receptor localization to postsynaptic specialization membrane(GO:0099645) |
0.1 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.9 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.1 | 2.3 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 0.3 | GO:0035937 | estrogen secretion(GO:0035937) regulation of estrogen secretion(GO:2000861) |
0.1 | 0.3 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.1 | 1.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.7 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 2.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.4 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.1 | 1.1 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.6 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.2 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
0.1 | 0.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.3 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
0.1 | 1.3 | GO:0050802 | circadian sleep/wake cycle process(GO:0022410) circadian sleep/wake cycle, sleep(GO:0050802) |
0.1 | 0.6 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 1.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.5 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 1.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 1.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) negative regulation of mitochondrial depolarization(GO:0051902) |
0.1 | 0.3 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.1 | 0.6 | GO:0021571 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.1 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.1 | 4.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.1 | 0.7 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 0.1 | GO:2001188 | negative regulation of immunological synapse formation(GO:2000521) regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001188) negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001189) |
0.1 | 0.8 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 1.2 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 1.0 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.3 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.1 | 1.7 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.1 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.2 | GO:0072143 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) |
0.1 | 0.4 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.5 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 1.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.3 | GO:0072708 | response to sorbitol(GO:0072708) response to dithiothreitol(GO:0072720) |
0.1 | 1.3 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.6 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 1.6 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 2.3 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 1.4 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.7 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 0.3 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 | 0.8 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.6 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.3 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.1 | 0.4 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.4 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.1 | 0.5 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.1 | 0.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.4 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 1.0 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.1 | 1.1 | GO:0009251 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.2 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 0.7 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 1.3 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.1 | 0.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.3 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
0.1 | 2.3 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 0.2 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.1 | 0.1 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.1 | 0.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.2 | GO:1904170 | regulation of bleb assembly(GO:1904170) |
0.1 | 3.4 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 1.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.4 | GO:0003266 | regulation of secondary heart field cardioblast proliferation(GO:0003266) positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.3 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.3 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.1 | 0.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.3 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.1 | 0.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.2 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.1 | 0.6 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.4 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 1.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.6 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 2.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.3 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.1 | 0.5 | GO:1901909 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.1 | 0.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.1 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.1 | 0.5 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 0.7 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.1 | 0.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.1 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
0.1 | 0.6 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.6 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.6 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.7 | GO:0072656 | regulation of anion channel activity(GO:0010359) maintenance of protein location in mitochondrion(GO:0072656) |
0.1 | 0.2 | GO:2000742 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.1 | 0.4 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 3.7 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.6 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.3 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.3 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.1 | 0.5 | GO:0003283 | atrial septum development(GO:0003283) |
0.1 | 0.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.5 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.1 | 0.6 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.3 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.6 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 0.2 | GO:0003127 | detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) |
0.1 | 0.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.1 | 0.9 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.5 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 1.1 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 1.2 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 3.4 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.1 | 0.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.2 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.1 | 0.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.5 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.2 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.5 | GO:0090003 | regulation of Golgi to plasma membrane protein transport(GO:0042996) regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.1 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.2 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
0.1 | 0.6 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.1 | 0.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.5 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.1 | GO:0060558 | regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.1 | 0.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 5.6 | GO:0007586 | digestion(GO:0007586) |
0.1 | 0.3 | GO:1990266 | neutrophil migration(GO:1990266) |
0.1 | 0.7 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.1 | 0.7 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.3 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.9 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.2 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.1 | 0.4 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.6 | GO:0006568 | tryptophan metabolic process(GO:0006568) tryptophan catabolic process(GO:0006569) indolalkylamine metabolic process(GO:0006586) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
0.1 | 0.2 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.1 | 0.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.6 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.2 | GO:0043102 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 0.7 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 1.6 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.1 | 0.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.7 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.1 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 0.7 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.1 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.1 | 0.1 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.1 | 0.2 | GO:0032701 | regulation of interleukin-18 production(GO:0032661) negative regulation of granulocyte macrophage colony-stimulating factor production(GO:0032685) negative regulation of interleukin-18 production(GO:0032701) |
0.1 | 0.3 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.1 | 0.6 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.1 | 0.5 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.2 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.1 | 0.3 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.1 | 1.0 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.2 | GO:0009397 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.1 | 0.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 1.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.2 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.1 | 0.3 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.3 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.2 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.1 | 0.2 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.1 | 0.4 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.2 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.1 | 0.7 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.5 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 0.6 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.8 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.6 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.2 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.5 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.1 | 0.2 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.1 | 0.2 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.1 | 0.5 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.1 | 0.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.3 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.8 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.1 | 0.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.5 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 1.2 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.1 | 0.3 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) response to L-glutamate(GO:1902065) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.1 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.2 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.1 | 0.2 | GO:0006788 | heme oxidation(GO:0006788) |
0.1 | 0.1 | GO:0072014 | proximal tubule development(GO:0072014) |
0.1 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 4.0 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.1 | 0.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.1 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.1 | 1.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.2 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.1 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.1 | 0.4 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.5 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.3 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.1 | 0.8 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.1 | 0.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.3 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.1 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.1 | 0.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.0 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 1.7 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.0 | 3.3 | GO:0009308 | amine metabolic process(GO:0009308) |
0.0 | 0.0 | GO:2000650 | negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.0 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.8 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.6 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.1 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 1.0 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.0 | 0.1 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.0 | 0.2 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.0 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 1.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.7 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 1.9 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 1.0 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.0 | 1.6 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.0 | 3.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.1 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.0 | 0.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) regulation of vascular wound healing(GO:0061043) |
0.0 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 1.2 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.4 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.2 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.0 | 0.1 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.0 | 0.0 | GO:0035812 | renal sodium excretion(GO:0035812) |
0.0 | 0.1 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.0 | 0.2 | GO:0003177 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.0 | 0.3 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.0 | 0.1 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.6 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.2 | GO:1904861 | regulation of receptor localization to synapse(GO:1902683) excitatory synapse assembly(GO:1904861) |
0.0 | 0.5 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.7 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.5 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.4 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.0 | 0.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.0 | 2.2 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.3 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.0 | 1.6 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.1 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.0 | 0.3 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.0 | 0.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.2 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.1 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.0 | 0.1 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.5 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.0 | 0.4 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 4.1 | GO:0007416 | synapse assembly(GO:0007416) |
0.0 | 0.2 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.1 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.0 | 0.0 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 0.2 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.0 | 1.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.6 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.1 | GO:0019230 | proprioception(GO:0019230) |
0.0 | 0.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.1 | GO:0035553 | oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.6 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 1.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 1.6 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.2 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.0 | 0.1 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.0 | 0.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.9 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0015812 | gamma-aminobutyric acid secretion(GO:0014051) gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.5 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.9 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.0 | 0.1 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.0 | 0.3 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.0 | 0.2 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.0 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
0.0 | 0.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.2 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.0 | 2.0 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.0 | 0.3 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.4 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
0.0 | 0.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.0 | 0.1 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.0 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.3 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.2 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.2 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.9 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.5 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.5 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.3 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.3 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.0 | 0.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.6 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.3 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.5 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 0.2 | GO:0051096 | maintenance of DNA repeat elements(GO:0043570) regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.0 | 0.3 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.8 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.6 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.0 | 0.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.5 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 0.4 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.1 | GO:0032963 | collagen metabolic process(GO:0032963) |
0.0 | 0.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.2 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.0 | 0.1 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.0 | 0.1 | GO:1990743 | protein sialylation(GO:1990743) negative regulation of macrophage apoptotic process(GO:2000110) |
0.0 | 1.8 | GO:0048839 | inner ear development(GO:0048839) |
0.0 | 1.4 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.0 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.2 | GO:0032967 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.0 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.0 | 0.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.0 | 0.2 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.0 | 0.3 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.2 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.1 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) positive regulation of neutrophil apoptotic process(GO:0033031) positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.0 | 0.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.0 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.2 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.3 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.0 | 0.1 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.1 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) dopamine biosynthetic process(GO:0042416) catecholamine biosynthetic process(GO:0042423) |
0.0 | 0.1 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.0 | 0.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.7 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.0 | 0.4 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.0 | 0.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.1 | GO:0051693 | actin filament capping(GO:0051693) |
0.0 | 0.0 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.0 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.1 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.2 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.2 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.0 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.0 | 0.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.1 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.0 | 0.1 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.1 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.1 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.1 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.3 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.0 | 0.3 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.1 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) regulation of relaxation of cardiac muscle(GO:1901897) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.9 | 3.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.7 | 5.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.6 | 2.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.5 | 2.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.5 | 2.0 | GO:0044393 | microspike(GO:0044393) |
0.5 | 1.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.5 | 2.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.5 | 1.9 | GO:0071953 | elastic fiber(GO:0071953) |
0.5 | 1.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.4 | 3.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 3.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 1.6 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.4 | 1.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.4 | 11.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.4 | 1.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.4 | 5.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.3 | 1.3 | GO:1990796 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) photoreceptor cell terminal bouton(GO:1990796) |
0.3 | 1.3 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.3 | 0.9 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 1.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 1.5 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.3 | 2.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.3 | 1.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 5.9 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.3 | 7.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 1.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 1.0 | GO:0005914 | spot adherens junction(GO:0005914) |
0.3 | 1.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 1.0 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 6.4 | GO:0034706 | sodium channel complex(GO:0034706) |
0.3 | 2.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 5.1 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 3.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 2.3 | GO:0002177 | manchette(GO:0002177) |
0.2 | 5.1 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 2.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 0.2 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 2.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 1.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 1.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 0.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 0.8 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.2 | 0.6 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 0.6 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.2 | 0.8 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 4.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 1.3 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.2 | 0.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 2.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.5 | GO:0098855 | HCN channel complex(GO:0098855) |
0.2 | 0.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 2.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 1.1 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.2 | 9.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.7 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 0.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 0.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.2 | 0.8 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.2 | 3.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 2.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 1.3 | GO:0097227 | sperm annulus(GO:0097227) |
0.1 | 0.6 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.1 | 4.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.6 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.6 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.1 | 1.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 1.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 1.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 2.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.4 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.1 | 0.8 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.6 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 1.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 1.0 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 1.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.6 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.7 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.8 | GO:0097444 | spine apparatus(GO:0097444) |
0.1 | 1.4 | GO:0005767 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
0.1 | 1.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 1.2 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.5 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 1.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 1.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.3 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 2.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 2.9 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 1.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.7 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 3.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 1.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.7 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 1.1 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 1.0 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 1.4 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 1.0 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 1.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 1.4 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.7 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 1.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 1.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.3 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.1 | 0.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.1 | 0.2 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.1 | 0.7 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 0.4 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.1 | 0.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 4.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 6.4 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.2 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.1 | 0.3 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 0.3 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.1 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.5 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 1.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 1.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.5 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.1 | 0.5 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.3 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 0.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.4 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 1.6 | GO:0034358 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.1 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.2 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 0.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.3 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.5 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.9 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 5.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.4 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 0.3 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.2 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 0.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 2.0 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.6 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.1 | 66.5 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.7 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.1 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.0 | 0.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.1 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.0 | 0.1 | GO:0090533 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) |
0.0 | 0.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 5.7 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.0 | 0.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 1.4 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.0 | 0.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.4 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 1.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 1.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.2 | GO:0097441 | basilar dendrite(GO:0097441) |
0.0 | 0.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 2.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 4.2 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.0 | 0.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 2.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 1.1 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.2 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.0 | 0.9 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.9 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 6.1 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.3 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 7.3 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.3 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.1 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.0 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.0 | 0.1 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.0 | 0.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 1.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 1.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 1.9 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 6.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.6 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.0 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.0 | 0.0 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 0.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 22.1 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 2.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.4 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 12.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.0 | GO:0060187 | cell pole(GO:0060187) |
0.0 | 0.3 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.2 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 3.1 | GO:0097708 | intracellular vesicle(GO:0097708) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 6.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
1.2 | 4.9 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.1 | 3.3 | GO:0016824 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
1.1 | 3.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.1 | 4.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.9 | 2.8 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.9 | 2.8 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.9 | 3.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.9 | 6.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.8 | 2.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.8 | 2.3 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.7 | 2.9 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.7 | 4.9 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.7 | 2.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.6 | 2.6 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.6 | 1.8 | GO:0045353 | interleukin-1, Type II receptor binding(GO:0005151) interleukin-1 receptor antagonist activity(GO:0005152) interleukin-1 Type I receptor antagonist activity(GO:0045352) interleukin-1 Type II receptor antagonist activity(GO:0045353) |
0.6 | 1.7 | GO:0070905 | serine binding(GO:0070905) |
0.5 | 4.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.5 | 4.1 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.5 | 3.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.5 | 1.6 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.5 | 3.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.5 | 3.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.5 | 2.5 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.5 | 2.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.5 | 1.4 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.5 | 1.4 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.5 | 6.2 | GO:0016918 | retinal binding(GO:0016918) |
0.5 | 1.9 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.5 | 3.7 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.5 | 2.8 | GO:0002054 | nucleobase binding(GO:0002054) |
0.5 | 1.4 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.4 | 1.8 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.4 | 1.3 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.4 | 1.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.4 | 2.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 2.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 4.6 | GO:0051870 | methotrexate binding(GO:0051870) |
0.4 | 1.3 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.4 | 1.2 | GO:0019002 | GMP binding(GO:0019002) |
0.4 | 1.6 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.4 | 1.2 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.4 | 1.6 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.4 | 1.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.4 | 1.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 0.7 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.4 | 1.1 | GO:0005118 | sevenless binding(GO:0005118) |
0.4 | 1.8 | GO:0034584 | piRNA binding(GO:0034584) |
0.4 | 0.7 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.4 | 1.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 0.7 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.3 | 3.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.3 | 5.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 1.0 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.3 | 1.9 | GO:0031404 | chloride ion binding(GO:0031404) |
0.3 | 1.0 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
0.3 | 1.3 | GO:0019863 | IgE binding(GO:0019863) |
0.3 | 0.9 | GO:0004335 | galactokinase activity(GO:0004335) |
0.3 | 0.6 | GO:0048030 | disaccharide binding(GO:0048030) |
0.3 | 2.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 1.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.3 | 1.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.3 | 4.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 3.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 1.8 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.3 | 0.9 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.3 | 1.2 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.3 | 1.1 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.3 | 0.8 | GO:0001566 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.3 | 0.8 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.3 | 0.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 2.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 1.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 0.8 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 2.7 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.3 | 1.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 2.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 0.5 | GO:0046977 | TAP binding(GO:0046977) |
0.3 | 2.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 1.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 1.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 2.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 1.8 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.3 | 3.8 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.3 | 1.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 1.0 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.3 | 0.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 1.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 1.7 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 2.9 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 0.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 1.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.2 | 0.7 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.2 | 0.7 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.2 | 0.7 | GO:0090556 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.2 | 5.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 1.6 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.2 | 4.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.2 | 7.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 1.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 2.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 1.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 0.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 2.6 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 3.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 9.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 0.6 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.2 | 0.6 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.2 | 1.1 | GO:0032810 | sterol response element binding(GO:0032810) |
0.2 | 2.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.2 | 0.6 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 1.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 1.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 1.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 2.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.2 | 5.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 0.6 | GO:0071568 | UFM1 transferase activity(GO:0071568) |
0.2 | 0.8 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.2 | 0.6 | GO:0047936 | glucose 1-dehydrogenase [NAD(P)] activity(GO:0047936) |
0.2 | 0.6 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.2 | 0.6 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.2 | 0.8 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.2 | 0.6 | GO:0031893 | vasopressin receptor binding(GO:0031893) V2 vasopressin receptor binding(GO:0031896) |
0.2 | 1.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 0.6 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.2 | 0.6 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 1.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.6 | GO:0019807 | aspartoacylase activity(GO:0019807) |
0.2 | 3.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 2.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 1.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 0.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 2.7 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.3 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 1.1 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.2 | 1.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.7 | GO:0004103 | choline kinase activity(GO:0004103) |
0.2 | 2.7 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 1.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 5.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.2 | 0.7 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 1.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 0.8 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.2 | 0.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 2.0 | GO:0015250 | water channel activity(GO:0015250) |
0.2 | 1.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 1.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 2.9 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 0.9 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 0.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) bile acid receptor activity(GO:0038181) |
0.2 | 2.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 24.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.6 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 4.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 2.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.9 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 3.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 1.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 1.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 3.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.4 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 1.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.5 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 4.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 1.3 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 2.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 1.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 0.6 | GO:0015100 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.1 | 1.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 1.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 1.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.8 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.1 | 0.9 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.9 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.3 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 6.6 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.5 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 2.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 3.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 1.6 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.4 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.1 | 0.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.4 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.6 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.1 | 0.3 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.1 | 0.6 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.9 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.8 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.4 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 0.5 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 1.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 5.2 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.3 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 0.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.4 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.1 | 0.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.7 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 0.2 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.1 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.3 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 1.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 1.3 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.4 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.1 | 2.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.5 | GO:0034432 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.1 | 0.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.4 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.3 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.1 | 0.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.8 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 1.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.5 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.2 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.1 | 4.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 2.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 4.3 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 2.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 3.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 0.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 1.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.2 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.1 | 1.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.8 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.7 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.6 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.1 | 0.3 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.1 | 3.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.5 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.5 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 1.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.3 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.2 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.1 | 0.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.2 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.1 | 0.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 0.4 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 1.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.3 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.1 | 0.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.4 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 2.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.2 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.1 | 0.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.2 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.1 | 0.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 1.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.4 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.1 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.2 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.2 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.2 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.1 | 1.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.2 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.1 | 0.2 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.3 | GO:0051998 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.1 | 1.6 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.1 | 0.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.8 | GO:0004601 | peroxidase activity(GO:0004601) |
0.1 | 0.2 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) |
0.1 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.7 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.9 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 2.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.2 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.3 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.0 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.0 | 0.8 | GO:0004629 | phosphatidylinositol phospholipase C activity(GO:0004435) phospholipase C activity(GO:0004629) |
0.0 | 2.4 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.0 | 0.0 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.0 | 2.5 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.0 | 1.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.2 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.0 | 0.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 1.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 7.0 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.0 | 0.1 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.0 | 1.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 1.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 1.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.5 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 1.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.0 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.5 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.2 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.0 | 0.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.0 | 0.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.2 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 1.0 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.2 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.4 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 0.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.1 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
0.0 | 0.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 1.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.7 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.0 | 0.6 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 9.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.1 | GO:0070287 | ferritin receptor activity(GO:0070287) |
0.0 | 1.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.2 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 1.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.0 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.0 | 0.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.2 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 0.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.1 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.0 | 0.1 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.1 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.0 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 3.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.8 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.0 | 0.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 2.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.0 | 0.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.5 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.1 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 4.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 3.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 6.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 2.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 24.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 2.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 4.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 5.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 0.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 14.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 1.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 2.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 3.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 5.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 5.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 13.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 2.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 16.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.5 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 1.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 1.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 1.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 2.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 1.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.8 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.1 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 1.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.3 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 1.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.4 | 0.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 6.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 6.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 3.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 3.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.3 | 7.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 5.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 3.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 3.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 6.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 2.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 3.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 2.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 4.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 1.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 3.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 0.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 3.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 0.2 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 7.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 5.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 2.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 1.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 3.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 20.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.7 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 2.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 3.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 2.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 3.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 2.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 10.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 1.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 0.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 1.6 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 1.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 4.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 2.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.8 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.1 | 0.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 4.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 1.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 4.8 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 0.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 2.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 3.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 2.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 2.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 2.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 1.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 2.7 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 4.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 2.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 1.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 1.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.5 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 1.4 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 1.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 1.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 1.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.9 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.7 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.8 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.3 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |